304 related articles for article (PubMed ID: 25013376)
1. Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma.
Xu WH; Zhang JB; Dang Z; Li X; Zhou T; Liu J; Wang DS; Song WJ; Dou KF
Int J Biol Sci; 2014; 10(7):664-76. PubMed ID: 25013376
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
3. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
Zhang Q; Cheng S; Cao L; Yang J; Wang Y; Chen Y
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32077915
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK/ERK pathway.
He H; Chen T; Mo H; Chen S; Liu Q; Guo C
Biochem Biophys Res Commun; 2020 Dec; 533(4):886-892. PubMed ID: 33008585
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
Peng W; Fan H
Biomed Pharmacother; 2016 Oct; 83():450-455. PubMed ID: 27427851
[TBL] [Abstract][Full Text] [Related]
6. Effect of long non-coding RNA H19 on oxidative stress and chemotherapy resistance of CD133+ cancer stem cells via the MAPK/ERK signaling pathway in hepatocellular carcinoma.
Ding K; Liao Y; Gong D; Zhao X; Ji W
Biochem Biophys Res Commun; 2018 Jul; 502(2):194-201. PubMed ID: 29800569
[TBL] [Abstract][Full Text] [Related]
7. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
8. Effects of long non-coding RNA URHC on proliferation, apoptosis and invasion of colorectal cancer cells.
Gu ZG; Shen GH; Lang JH; Huang WX; Qian ZH; Qiu J
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1658-1664. PubMed ID: 29630109
[TBL] [Abstract][Full Text] [Related]
9. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
10. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.
Ni W; Zhang Y; Zhan Z; Ye F; Liang Y; Huang J; Chen K; Chen L; Ding Y
J Hematol Oncol; 2017 Apr; 10(1):91. PubMed ID: 28420424
[TBL] [Abstract][Full Text] [Related]
11. Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma.
Pan YF; Qin T; Feng L; Yu ZJ
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):96-101. PubMed ID: 23392715
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
14. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma.
Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z
BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994
[TBL] [Abstract][Full Text] [Related]
16. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
17. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma.
Xiao J; Lv Y; Jin F; Liu Y; Ma Y; Xiong Y; Liu L; Zhang S; Sun Y; Tipoe GL; Hong A; Xing F; Wang X
Cell Physiol Biochem; 2017; 43(5):1926-1938. PubMed ID: 29055955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
